New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - aciclovir 25 mg/ml;   - solution for injection - 25 mg/ml - active: aciclovir 25 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - aciclovir 25 mg/ml;   - solution for infusion - 25 mg/ml - active: aciclovir 25 mg/ml   excipient: hydrochloric acid sodium hydroxide - q.s. to ph nitrogen sodium hydroxide water for injection - - treatment of herpes simplex infections. - prophylaxis of herpes simplex infections in immune-compromised patients. - treatment of varicella zoster infections. - the treatment of herpes simplex infections in the neonate. - prophylaxis of cmv infection in bone marrow transplant recipients. it has been shown that high dose intravenous aciclovir reduces the incidence and delays the onset of cmv infection. when high dose intravenous aciclovir is followed by 6 months treatment with high dose oral aciclovir (see prescribing information for oral aciclovir) mortality and the incidence of viraemia are also reduced.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - aciclovir 25 mg/ml - solution for infusion - 25 mg/ml - active: aciclovir 25 mg/ml excipient: sodium hydroxide water for injection - dbl aciclovir intravenous infusion is indicated for: - treatment of herpes simplex infections. - prophylaxis of herpes simplex infections in immune-compromised patients. - treatment of varicella zoster infections. - the treatment of herpes simplex infections in the neonate. - prophylaxis of cmv infection in bone marrow transplant recipients. it has been shown that high dose intravenous aciclovir reduces the incidence and delays the onset of cmv infection. when high dose intravenous aciclovir is followed by 6 months treatment with high dose oral aciclovir (see prescribing information for oral aciclovir) mortality and the incidence of viraemia are also reduced.

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira uk limited - aciclovir sodium - concentrate for soln for inf - 25 mg/ml - nucleosides and nucleotides excl. reverse transcriptase inhibitors

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hospira benelux bv-srl - aciclovir sodium - eq. aciclovir 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - aciclovir sodium - aciclovir

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hospira benelux bv-srl - aciclovir sodium - eq. aciclovir 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - aciclovir sodium - aciclovir

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hospira benelux bv-srl - aciclovir sodium - eq. aciclovir 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - aciclovir sodium - aciclovir

Ireland - English - HPRA (Health Products Regulatory Authority)

claris lifesciences (uk) limited - aciclovir - concentrate for soln for inf - 25 mg/ml - nucleosides and nucleotides excl. reverse transcriptase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - aciclovir - concentrate for solution for infusion - 25 milligram(s)/millilitre - nucleosides and nucleotides excl. reverse transcriptase inhibitors; aciclovir

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - aciclovir sodium - concentrate for solution for infusion - 25 milligram(s)/millilitre - nucleosides and nucleotides excl. reverse transcriptase inhibitors; aciclovir